MADIT II trial: A 2002 breakthrough in primary prevention of mortality with implantable cardioverter-defibrillator

被引：0
作者：
Zareba, Wojciech [1 ]
机构：
[1] Univ Rochester, Clin Cardiovasc Res Ctr, Med Ctr, Cardiol Div, 601 Elmwood Ave,Box 653, Rochester, NY 14642 USA
来源：
HEART RHYTHM | 2025年 / 22卷 / 04期
关键词：
RISK;
D O I：
10.1016/j.hrthm.2025.02.019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：882 / 883
页数：2
相关论文
共 50 条
  • [41] Cardiac resynchronization therapy is associated with reductions in left atrial volume and inappropriate implantable cardioverter-defibrillator therapy in MADIT-CRT
    Slyngstad, Tyler
    Ruwald, Anne-Christine Huth
    Kutyifa, Valentina
    McNitt, Scott
    Polonsky, Bronislava
    Solomon, Scott D.
    Foster, Elyse
    Goldenberg, Ilan
    Wang, Paul J.
    Klein, Helmut
    Zareba, Wojciech
    Moss, Arthur J.
    [J]. HEART RHYTHM, 2014, 11 (06) : 1001 - 1007
  • [42] Prediction of benefits from prophylactic implantable cardioverter-defibrillator therapy
    Huikuri, Heikki V.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 243 : 274 - 275
  • [43] Prognostic Importance of Atrial Fibrillation in Implantable Cardioverter-Defibrillator Patients
    Borleffs, C. Jan Willem
    van Rees, Johannes B.
    van Welsenes, Guido H.
    van der Velde, Enno T.
    van Erven, Lieselot
    Bax, Jeroen J.
    Schalij, Martin J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (09) : 879 - 885
  • [44] Implantable cardioverter-defibrillator therapy in the elderly: The continuing quest for data
    Barsheshet, Alon
    Huang, David T.
    [J]. CARDIOLOGY JOURNAL, 2011, 18 (05) : 473 - 475
  • [45] Time to revisit implantable cardioverter-defibrillator implantation criteria in women
    Barra, Sergio
    Narayanan, Kumar
    Garcia, Rodrigue
    Marijon, Eloi
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (11) : 1110 - 1112
  • [46] Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction
    Tracy, Cynthia M.
    [J]. HEART RHYTHM, 2011, 8 (03) : 401 - 402
  • [47] Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy
    Francia, Pietro
    Adduci, Carmen
    Palano, Francesca
    Semprini, Lorenzo
    Serdoz, Andrea
    Montesanti, Dalma
    Santini, Daria
    Musumeci, Beatrice
    Salvati, Adriano
    Volpe, Massimo
    Autore, Camillo
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2015, 26 (08) : 893 - 899
  • [48] Feasibility of Early Discharge After Implantable Cardioverter-Defibrillator Procedures
    Choudhuri, Indrajit
    Desai, Dipan
    Walburg, Jon
    August, Phyllis
    Keller, Seth I.
    Suri, Ranjit
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2012, 23 (10) : 1123 - 1129
  • [49] Primary prevention of sudden death with the implantable cardioverter defibrillator: bridging the evidence gap
    Estes, N. A. Mark
    Saba, Samir
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 (36) : 3448 - 3450
  • [50] Long-term follow-up of children and young adults treated with implantable cardioverter-defibrillator: the authors' own experience with optimal implantable cardioverter-defibrillator programming
    Lewandowski, Michal
    Sterlinski, Maciej
    Maciag, Aleksander
    Syska, Pawel
    Kowalik, Ilona
    Szwed, Hanna
    Chojnowska, Lidia
    Przybylski, Andrzej
    [J]. EUROPACE, 2010, 12 (09): : 1245 - 1250
12345